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CPAP Effects on Cardiovascular 
Outcomes: Lipids and Liver Function
Grace Severance, Cynthia Cheng MDPhD*, Amy He**, Dani Yellanki**, Peter 
Zhang**, Zach Mace**, Olivia Taylor**, Natalia Salinas**
Introduction: Lipids
Continuous Positive Airway Pressure (CPAP) therapy has been shown to lower 
LDL-C, TC, TG, ALT, and AST, while increasing HDL-C. The degree of 
improvement has varied depending on CPAP therapy duration, compliance, and 
study design.
* Citations in powerpoint notes
Introduction: Liver Enzymes
The specific aim of the following 
retrospective chart review study is to 
determine if there is significant 
improvement in lipid panel and liver 
function test variables in patients that 
use CPAP therapy. 
Objectives
& Hypothesis
• Research Question: Does continuous positive airway 
pressure (CPAP) therapy improve lipid panels and liver 
function tests in patients with obstructive sleep apnea 
(OSA)?
• Hypothesis: Jefferson OSA patients (Sleep Center/ Family 
Medicine) who are adherent to CPAP therapy (defined as 
greater than 4 hours of use on average per night) will have 
lower LDL-C, TG, and TC, as well as increased HDL-C. 
Furthermore, AST and ALT enzymes will also be lower with 
consistent CPAP use. 
Approach & Results
• Study Design: retrospective chart review, goal 5000-10,000 
charts; planned follow up prospective review
• Population / study sample: Jefferson Family Medicine 
Department & Sleep Center patients
• Intervention: CPAP therapy
• Comparison group: non-OSA patients, CPAP-noncompliant 
patients
• Outcomes: HDL-C, LDL-C, TC, TG, ALT, AST, and liver US pathology 
(cysts, abscess, steatosis, cirrhosis, etc).
• Data source and collection: EPIC patient charts; Office365 Excel 
doc 
• My contribution:  Many hours/months spent on lit review 
developing individual aim; teamwork creating and refining the 
database and chart review protocol
Approach & Results: 
LFT’s and Lipids
• Analysis: pilot 10 chart statistical analysis - SAS version 9.4 - 2 
of 10 had lipid panels, 4 of 10 had liver function tests, 1 of 10 
had negative hepatic ultrasound
Approach & Results: Other 
Interesting Results
• Analysis: pilot 10 chart statistical analysis - SAS 
version 9.4
• 3 Controls, 7 CPAP intervention, so far all results are non-
significant due to small sample size
• ESS: decreased in sleepiness compared to controls
• Weight Change: slight increase in weight compared to controls
• NO correlation between BMI, blood pressure, heart rate, or 
blood glucose at baseline with AHI
• BP: paradoxical increase compared to controls (uncontrolled 
analysis due to very small sample size; could be due to 
medication use or other confounding factors)
Conclusions
• Limited data prevented significant conclusions 
regarding CPAP therapeutic effect on lipid 
panels and LFTs
• Further investigation/increased sample size in 
the coming year may support current 
literature that CPAP therapy improves lipid 
and liver values
Future Directions
• We have many MS1’s who are currently 
signed up to ramp up data collection
• Will continue working on data collection and 
publication as project progresses
• Demonstrating that CPAP therapy could 
provide a non-pharmaceutical benefit to 
patients beyond its clinical indications for OSA
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